Initial therapy for myasthenia gravis of combined therapy for tacrolimus and IVIG

Initial therapy for myasthenia gravis of combined therapy for tacrolimus and IVIG - Combined therapy for tacrolimus and IVIG

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015019

Enrollment

Registered

2014-09-02

Start date

2014-09-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia gravis

Interventions

Tacrolimus and IVIG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: MGFA class II-IV QMG score 9< Tensilon test positive No indication for thymectomy

Exclusion criteria

Exclusion criteria: indication for thymectomy

Design outcomes

Primary

Measure	Time frame
QMG score and MGFA post-intervention status	—

Countries

Japan

Contacts

Public Contactkengo fujita

kansai medical univ. neurology

fujitake@hirakata.kmu.ac.jp072-804-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026